Coty (NYSE:COTY) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. This is a 88.89 percent increase over losses of $(0.09) per share from the same period last year. The company reported quarterly sales of $1.17 billion which beat the analyst consensus estimate of $1.14 billion by 2.46 percent. This is a 9.98 percent increase over sales of $1.06 billion the same period last year.
Jaguar Health Granted Extension Until August 13, 2024, To Regain Compliance With Nasdaq’s Bid Price Requirement
Top line results forthcoming for company's phase 3 OnTarget trial of crofelemer for preventative treatment of cancer therapy-related diarrheaSAN FRANCISCO, CA / ACCESSWIRE / April 8, 2024 / Jaguar Health, Inc.
